aap bio implants group and partners are granted EUR 1 million in funding to develop and manufacture ultra-clean biopolymers

aap reports Nine-Month Sales of EUR 18.6 million (+31%) and EBIT of EUR 1.1 million EUR (-46%)

Fame Medical Group Takeover Completed Successfully

aap has new Supervisory Board Chairman

aap signed with Wright Medical Technology (WMT) a global distribution and supply agreement

aap acquires rights on Adcon® from Wright Medical Technologies

aap: Withdrawal of Motions for the August 27, 2007 Shareholders’ Meeting

aap posts first-half sales of EUR 12.7 million (+38%) and EBIT of EUR 0.8 million (-51%)

aap focus on implantable biomaterials

Q1 Sales up 35% close to Break-even Result after first-time Consolidation of Fame

Annual Financial Statements 2006: Sales +38%, Net Result for the Year +143%

Capital Increase Approved

Preliminary Sales Figures for Fiscal 2006 (+40%)